DE69424415D1 - Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit - Google Patents
Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheitInfo
- Publication number
- DE69424415D1 DE69424415D1 DE69424415T DE69424415T DE69424415D1 DE 69424415 D1 DE69424415 D1 DE 69424415D1 DE 69424415 T DE69424415 T DE 69424415T DE 69424415 T DE69424415 T DE 69424415T DE 69424415 D1 DE69424415 D1 DE 69424415D1
- Authority
- DE
- Germany
- Prior art keywords
- efaroxan
- disease
- derivatives
- producing
- medicinal product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- RATZLMXRALDSJW-UHFFFAOYSA-N 2-(2-ethyl-3H-benzofuran-2-yl)-4,5-dihydro-1H-imidazole Chemical compound C1C2=CC=CC=C2OC1(CC)C1=NCCN1 RATZLMXRALDSJW-UHFFFAOYSA-N 0.000 title abstract 2
- 208000018737 Parkinson disease Diseases 0.000 title abstract 2
- 229950001765 efaroxan Drugs 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9307379A FR2706303B1 (fr) | 1993-06-18 | 1993-06-18 | Utilisation de l'Efaroxan et de ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson. |
| PCT/FR1994/000715 WO1995000145A1 (fr) | 1993-06-18 | 1994-06-15 | Utilisation de l'efaroxan et de ses derives pour la preparation d'un medicament destine au traitement de la maladie de parkinson |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69424415D1 true DE69424415D1 (de) | 2000-06-15 |
| DE69424415T2 DE69424415T2 (de) | 2000-12-21 |
Family
ID=9448287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69424415T Expired - Fee Related DE69424415T2 (de) | 1993-06-18 | 1994-06-15 | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5948806A (de) |
| EP (1) | EP0703781B1 (de) |
| JP (1) | JP3394257B2 (de) |
| AT (1) | ATE192650T1 (de) |
| AU (1) | AU689783B2 (de) |
| CA (1) | CA2165437A1 (de) |
| DE (1) | DE69424415T2 (de) |
| DK (1) | DK0703781T3 (de) |
| ES (1) | ES2147576T3 (de) |
| FR (1) | FR2706303B1 (de) |
| GR (1) | GR3034062T3 (de) |
| NZ (1) | NZ268039A (de) |
| PT (1) | PT703781E (de) |
| WO (1) | WO1995000145A1 (de) |
| ZA (1) | ZA944281B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6281207B1 (en) * | 1999-09-15 | 2001-08-28 | Reed Richter | Treatment of movement disorders by administration of mirtazapine |
| FR2814368B1 (fr) * | 2000-09-26 | 2004-05-07 | Pf Medicament | Preparation pharmaceutique a base d'oxans |
| WO2002039991A2 (en) * | 2000-11-14 | 2002-05-23 | Orion Corporation | Prevention of development of dyskinesias |
| US8188126B2 (en) | 2002-05-16 | 2012-05-29 | Pierre Fabre Medicament | Imidazolic compounds and use thereof as alpha-2 adrenergic receptors |
| WO2014172372A1 (en) | 2013-04-15 | 2014-10-23 | Northwestern University | Treatment for dopaminergic disorders |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ201219A (en) * | 1981-07-28 | 1984-10-19 | Reckitt & Colmann Prod Ltd | Dihydrobenzofuranyl-2-imidazolines and pharmaceutical compositions |
| FR2669030B1 (fr) * | 1990-11-14 | 1992-12-31 | Adir | Nouveaux derives d'imidazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| US5281607B1 (en) * | 1992-10-08 | 1998-05-19 | Univ New York | Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases |
-
1993
- 1993-06-18 FR FR9307379A patent/FR2706303B1/fr not_active Expired - Lifetime
-
1994
- 1994-06-15 EP EP94919712A patent/EP0703781B1/de not_active Expired - Lifetime
- 1994-06-15 WO PCT/FR1994/000715 patent/WO1995000145A1/fr active IP Right Grant
- 1994-06-15 PT PT94919712T patent/PT703781E/pt unknown
- 1994-06-15 AT AT94919712T patent/ATE192650T1/de not_active IP Right Cessation
- 1994-06-15 NZ NZ268039A patent/NZ268039A/xx unknown
- 1994-06-15 DE DE69424415T patent/DE69424415T2/de not_active Expired - Fee Related
- 1994-06-15 ES ES94919712T patent/ES2147576T3/es not_active Expired - Lifetime
- 1994-06-15 JP JP50249995A patent/JP3394257B2/ja not_active Expired - Fee Related
- 1994-06-15 CA CA002165437A patent/CA2165437A1/fr not_active Abandoned
- 1994-06-15 AU AU70764/94A patent/AU689783B2/en not_active Ceased
- 1994-06-15 DK DK94919712T patent/DK0703781T3/da active
- 1994-06-16 ZA ZA944281A patent/ZA944281B/xx unknown
-
1997
- 1997-03-26 US US08/825,414 patent/US5948806A/en not_active Expired - Fee Related
-
2000
- 2000-07-28 GR GR20000401754T patent/GR3034062T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2165437A1 (fr) | 1994-12-19 |
| DK0703781T3 (da) | 2000-10-02 |
| DE69424415T2 (de) | 2000-12-21 |
| EP0703781A1 (de) | 1996-04-03 |
| FR2706303A1 (fr) | 1994-12-23 |
| PT703781E (pt) | 2000-10-31 |
| JPH09500375A (ja) | 1997-01-14 |
| GR3034062T3 (en) | 2000-11-30 |
| AU7076494A (en) | 1995-01-17 |
| ATE192650T1 (de) | 2000-05-15 |
| FR2706303B1 (fr) | 1995-09-08 |
| AU689783B2 (en) | 1998-04-09 |
| US5948806A (en) | 1999-09-07 |
| WO1995000145A1 (fr) | 1995-01-05 |
| JP3394257B2 (ja) | 2003-04-07 |
| EP0703781B1 (de) | 2000-05-10 |
| ZA944281B (en) | 1995-02-10 |
| NZ268039A (en) | 1999-06-29 |
| ES2147576T3 (es) | 2000-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69636343D1 (de) | Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen | |
| DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| ATE330593T1 (de) | Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen | |
| ATE205086T1 (de) | Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit | |
| DE3876877D1 (de) | Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus. | |
| DE69713620D1 (de) | Verwendung von arachidonsäure und/oder docohexaensäure zur herstellung eines arzneimittels zur behandlung von dyspraxia | |
| ATE217191T1 (de) | Verwendung von phanquinon zur behandlung von alzheimer's krankheit | |
| ATE162076T1 (de) | Verwendung von nadh und nadph zur herstellung eines arzneimittels zur behandlung von morbus alzheimer | |
| DE69026511D1 (de) | Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis | |
| ATE192929T1 (de) | Verwendung von dimeticon zur herstellung eines arzneimittels zur behandlung von aphthen und stomatitis | |
| DE69424415D1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
| DE69007065D1 (de) | Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten. | |
| DE68905657D1 (de) | Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen. | |
| ATE186640T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung neurogenerativer erkrankungen | |
| ATE189385T1 (de) | Verwendung von benzonaphtalene-derivaten zur herstellung eines arzneimittels zur behandlung von krankheiten des nervensystems | |
| DE69610045D1 (de) | Verwendung eines Rohpflanzenextraktes zur Herstellung eines Arzneimittels zur Behandlung von HIV-Infektionen | |
| ATE173921T1 (de) | Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen | |
| ATE320263T1 (de) | Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie | |
| ATE263565T1 (de) | Verwendung von 8,9-dehydroestron zur herstellung eines arzneimittels zur behandlung von durch freie radikale verursachte krankheiten | |
| ATE230608T1 (de) | Verwendung von bradykinin-antagonisten zur herstellung von arzneimitteln zur behandlung und prävention der alzheimer'schen krankheit | |
| HUP0004647A2 (hu) | Glükóz-amino-glükánok alkalmazása diabétesszel társult szembetegségek kezelésére szolgáló gyógyszerkészítmények előállítására | |
| ATE195072T1 (de) | Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen | |
| DE3777709D1 (de) | Verwendung von 3'azido-3'deoxythymidin zur herstellung eines arzneimittels zur behandlung von gardiasis. | |
| DE69629188D1 (de) | Verwendung von (r)-penciclovirtriphosphat zur herstellung eines arzneimittels zur behandlung von viruserkrankungen | |
| DE69223811D1 (de) | Verwendung eines homöopathisches Erzeugnisses zur Herstellung eines Arzneimittels für die Behandlung von metabolischen Krankheiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |